TACE+RFA Versus TACE Alone for Intermediate-stage Hepatocellular Carcinoma

Clinical trial NCT02435953 · COMPLETED

Trial details

NCT number: NCT02435953
Sponsor: Ming Zhao
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Chemoembolization, Therapeutic Ablation Techniques, RFA

Start date: 2015-05-01
Primary completion: 2025-10-01
Enrollment: 241

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.